PSIL vs. CNCR

Last updated Jun 24, 2026

PSIL (AdvisorShares Psychedelics ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. PSIL is actively managed, while CNCR is passively managed. PSIL charges 1.00%/yr vs 0.79%/yr for CNCR.

Performance

PSIL vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AdvisorShares Psychedelics ETF (PSIL) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

PSIL

• 1D: 0.56%
• 1M: 1.61%
• YTD: 25.04%
• 6M: 21.09%
• 1Y: 76.10%
• 3Y*: 10.43%
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PSIL vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
PSIL AdvisorShares Psychedelics ETF	37.32%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

PSIL vs. CNCR - Sectors Allocation Comparison

Sectors	PSIL	CNCR
Healthcare	100.0%	96.6%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	3.3%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

PSIL vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSIL

PSIL Risk / Return Rank: 60
PSIL Sharpe Ratio Rank: 63
PSIL Sortino Ratio Rank: 58
PSIL Omega Ratio Rank: 53
PSIL Calmar Ratio Rank: 79
PSIL Martin Ratio Rank: 50

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PSIL vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AdvisorShares Psychedelics ETF (PSIL) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PSIL	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	1.88	—	—
Sortino ratio: Return per unit of downside risk	2.50	—	—
Omega ratio: Gain probability vs. loss probability	1.30	—	—
Calmar ratio: Return relative to maximum drawdown	3.75	—	—
Martin ratio: Return relative to average drawdown	7.83	—	—

Drawdowns

PSIL vs. CNCR - Drawdown Comparison

The maximum PSIL drawdown since its inception was -92.72%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for PSIL and CNCR.

Drawdown Indicators

	PSIL	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-92.72%	0.00%	-92.72%
Max Drawdown (1Y) Largest decline over 1 year	-20.38%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-64.62%	—	—
Current Drawdown Current decline from peak	-75.68%	0.00%	-75.68%
Average Drawdown Average peak-to-trough decline	-76.71%	0.00%	-76.71%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.75%	—	—

Volatility

Volatility by Period

	PSIL	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.82%	—	—
Volatility (6M) Calculated over the trailing 6-month period	28.52%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	42.43%	0.00%	+42.43%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	62.98%	0.00%	+62.98%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	62.98%	0.00%	+62.98%

PSIL vs. CNCR - Expense Ratio Comparison

PSIL has a 1.00% expense ratio, which is higher than CNCR's 0.79% expense ratio.

Dividends

PSIL vs. CNCR - Dividend Comparison

PSIL's dividend yield for the trailing twelve months is around 7.94%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%
PSIL AdvisorShares Psychedelics ETF	7.94%	10.95%	1.49%	0.24%	2.91%

Frequently Asked Questions

Which ETF is better, PSIL or CNCR?

On fees, CNCR is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, PSIL or CNCR?

CNCR is cheaper with a 0.79% expense ratio, compared with 1.00% for PSIL.

Which ETF pays a higher dividend yield, PSIL or CNCR?

PSIL has the higher dividend yield at 7.94%, compared with 0.00% for CNCR.

What is the main difference between PSIL and CNCR?

They also come from different issuers: AdvisorShares and Exchange Traded Concepts. Their fees differ too: 1.00% for PSIL and 0.79% for CNCR.